Funded Startups in Limburg
Disclosed funding amounts in Limburg skew sharply: Mosa Meat’s $42M round (2024-04-16) is the only disclosed round above $10M, coming well above the next-l…
Disclosed funding amounts in Limburg skew sharply: Mosa Meat’s $42M round (2024-04-16) is the only disclosed round above $10M, coming well above the next-largest disclosed amounts such as Neuroplast’s $11M (2021-11-17) and Corporis Medical’s $4M (2023-12-07). A second concentration appears in the middle of the window shown: from 2024-01-10 (Qorium, undisclosed) through 2024-04-16 (Mosa Meat, $42M), multiple biotech and health-adjacent deals appear across Maastricht and nearby Limburg cities.
The list spans 2021-06-22 (Kwarts, $1M) to the most recent 2025-05-26 (ResultX, $480K), with 19 rows total. Stage labels are missing or not specified frequently: “Series Unknown” appears in 10 of 19 rows, while “undisclosed” amounts show up in 2 rows (Mainichi Digital on 2024-07-05; Qorium on 2024-01-10). Sectors with 3+ entries cluster around Health Care/Biotech/AI: “Artificial Intelligence (AI)” appears 3 times (2021-11-30, 2021-06-22, 2025-05-26), and Biotechnology appears 4 times (2025-02-04 through 2023-12-26), indicating repeated investor attention across life sciences and data-driven tooling.
Most recent rounds
19 shownRelated listings
Frequently asked
Which disclosed round is an outlier in this Limburg set, and what sits next to it?
Mosa Meat’s $42M (2024-04-16) is the outlier: it is the only disclosed amount above $10M in the 19 rows. The next-largest disclosed amounts are Neuroplast’s $11M (2021-11-17) and Raw Stadia/Hyperfox’s $2M-class rounds do not come close.
Do deal dates cluster into a specific window within 2021–2025?
Yes. Several of the most active months fall in early 2024, with entries spanning 2024-01-10 (Qorium, undisclosed), 2024-03-11 (Safe Orthopaedics, $930K), and 2024-04-16 (Mosa Meat, $42M). That contrasts with fewer entries in late 2021 (e.g., PlayTreks $400K on 2021-11-30 and Neuroplast $11M on 2021-11-17).
Are there over-represented sectors or repeated categories of company activity?
Biotechnology appears 4 times (Tavira Therapeutics $360K on 2025-02-04; Qorium undisclosed on 2024-01-10; Temple Therapeutics $330K on 2023-12-26; OncoLize $2M on 2023-04-13), and Health Care appears 3 times (Safe Orthopaedics $930K on 2024-03-11; Corporis Medical $4M on 2023-12-07; Neuroplast $11M on 2021-11-17). Artificial Intelligence (AI) also repeats 3 times (ResultX $480K on 2025-05-26; PlayTreks $400K on 2021-11-30; Kwarts $1M on 2021-06-22).
How dominant are unspecified series labels, and how does that affect interpreting “largest round” comparisons?
“Series Unknown” appears in 10 of 19 rows, and “undisclosed” amounts appear in 2 rows (Mainichi Digital on 2024-07-05; Qorium on 2024-01-10). That means largest-round comparisons rely heavily on disclosed amounts such as Mosa Meat’s $42M (2024-04-16) rather than series/amount patterns in the missing-data rows.
Which cities show repeated activity, and is the pattern mainly Hasselt/Maastricht?
Hasselt appears multiple times with AI/IT and earlier-stage funding labels, including ResultX in Hasselt (2025-05-26, $480K), Hyperfox in Hasselt (2025-01-01, $2M), and Raw Stadia in Hasselt (2023-12-13, $2M). Maastricht also repeats across life sciences and health-adjacent companies, including Mosa Meat ($42M, 2024-04-16), Corporis Medical ($4M, 2023-12-07), and Temple Therapeutics ($330K, 2023-12-26).
What does the stage mix look like among the disclosed rounds—are later rounds or early rounds more common?
Early-stage labels show up frequently among disclosed entries: Seed rounds include Hyperfox $2M (2025-01-01), Raw Stadia $2M (2023-12-13), and Aerial Precision $760K (2022-08-25), while Pre-Seed includes PlayTreks $400K (2021-11-30). Larger disclosed rounds include Seed-class $2M deals and standout later-stage examples such as Series B entries—Corporis Medical $4M (2023-12-07) and Neuroplast $11M (2021-11-17)—but Series B appears less often than Seed/other early labels.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.